Skip to content

Waters Corporation WAT Waters Advanced Diagnostics — Goodwill

Similar metrics at other companies

Idexx Laboratories logo
IDXXWater segment revenue — Goodwill
$18.41M+1.6%
Opko Health logo
OPKDiagnostics — Goodwill
$163.44M0.0%
HWK
HWKNWater Treatment — Goodwill
$170.88M+104%
Franklin Electric logo
FELEWater Systems — Goodwill
$278.6M+3.0%
Fortune Brands Innovations logo
FBINWater — Goodwill
$1.22B+0.5%
Select Water Solutions logo
WTTRWater Services — Goodwill
$1.44M0.0%

Other financials

Income statement

See full
Revenue$1.3B+91.4%
Gross profit$569.5M+8.6%
Operating income-$47.0M-131%
Net income-$72.0M-160%
EPS (diluted)-$0.87-143%

Balance sheet

See full
Cash & equivalents$462.0M+20.7%
Total debt$5.2B+263%
Total equity$15.3B+679%
Total assets$24.5B+434%

Cash flow

See full
Operating cash flow-$3.0M-101%
CapEx$39.0M+50.0%
Free cash flow-$42.0M-118%

Valuation

See full
Market cap$36.76B+78.1%
Enterprise value$41.51B+92.6%
P/E81.8×+50.6×
P/S9.8×+3.0×

Profitability

See full
Gross margin59.3%-0.1pp
Operating margin16%-12.3pp
Net margin11.9%-10.1pp
FCF margin7%-13.8pp

Returns & leverage

See full
Return on equity5.2%-35.6pp
Debt / equity0.3×-0.4×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Waters Corporation in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Waters Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Waters Corporation's waters advanced diagnostics — goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Waters Corporation's waters advanced diagnostics — goodwill?
Waters Corporation (WAT) reported waters advanced diagnostics — goodwill of $3.37B in Q1 2026.
What does waters advanced diagnostics — goodwill mean?
Represents the carrying value of goodwill specifically allocated to the Waters Advanced Diagnostics business segment. This asset arises when the purchase price of an acquired entity exceeds the fair value of its identifiable net assets, reflecting the premium paid for brand reputation and customer relationships within the diagnostics market.